One of many negative outcomes of PEG-MGF uncovered after animal testing is Hypoglycemia or ‘ lower blood sugar’. As PEG-MGF improves the performance of mobile operation, blood sugar achieves its purposeful target much too quickly Therefore causing Hypoglycemia.Sustained supply of MGF peptide from microrods appeals to stem cells and minimizes ap